Athersys has generated ($0.29) earnings per share over the last …
To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. 13, 2020 at 6:06 a.m.
Athersys - ATHX - Stock Price & News | The Motley Fool Latest Stock Picks Thank you for standing by, and welcome to the Athersys second-quarter 2020 results Conference Call. You can sign up for additional alert options at any time.At Athersys, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you do not have a copy of the press release issued at the close of market, it is available on the Athersys website at athersys.com.Investing legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free.When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...Acerus Reports Fiscal 2020 Second Quarter Financial ResultsHow Much Did K3 Business Technology Group's(LON:KBT) Shareholders Earn From Share Price Movements Over The Last Five Years?NV5 Global (NASDAQ:NVEE) Shareholders Have Enjoyed An Impressive 161% Share Price GainDiscover new investment ideas by accessing unbiased, in-depth investment researchNasdaqGS - NasdaqGS Real Time Price. Athersys last released its earnings data on May 7th, 2020. As Jesse mentioned, I'm Karen Hunady, director of corporate communications and investor relations for Athersys. Find the latest news headlines from Athersys, Inc. Common Stock (ATHX) at Nasdaq.com. The biopharmaceutical company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by $0.02. If you experience any issues with this process, please contact us for further assistance. After submitting your request, you will receive an activation email to the requested email address. If you experience any issues with this process, please contact us for further assistance. The MarketWatch News Department was not involved in the creation of this content. Real time Athersys (ATHX) stock price quote, stock graph, news & analysis. Currency in USD
You must click the activation link in order to complete your subscription. Athersys gets FDA OK for phase 2/3 to study MultiStem in patients with COVID-19-induced ARDS Apr. Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Get the latest Athersys, Inc. (ATHX) stock news and headlines to help you in your trading and investing decisions. At Athersys, Inc., we promise to treat your data with respect and will not share your information with any third party. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 33.30%.
Our focus is on the treatment of medical conditions where there is significant clinical need, and we are particularly focused on developing therapies in the regenerative medicine area. With the latest financial reports released by the company, Athersys Inc. posted -0.06/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share.